Ellen O'Connor Vos

Filings by Ellen O'Connor Vos span 3 companies, the busiest being Aspira Women's Health Inc., OptimizeRx Corp and Modular Medical, Inc. In total, 17 filings cover trades dated from 30 June 2021 to 11 June 2025.

Purchases make up the whole of the open-market record (3 purchases, €150k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants and 9 option exercises.

In size, the median ticket on the buying side is €14k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 12 June 2025 came the latest disclosure, a share grant in OptimizeRx Corp. The latest purchase dates back some time: it was published 1,180 days ago, on 26 July 2023. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.